MV Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Buy |
73
+35
| +92% | +$5.31K | ﹤0.01% | 510 |
|
|
2025
Q1 | $5.72K | Buy |
38
+17
| +81% | +$2.56K | ﹤0.01% | 599 |
|
|
2024
Q4 | $3.88K | Sell |
21
-5
| -19% | -$923 | ﹤0.01% | 632 |
|
|
2024
Q3 | $5.12K | Sell |
26
-3
| -10% | -$591 | ﹤0.01% | 625 |
|
|
2024
Q2 | $5.99K | Buy |
29
+5
| +21% | +$1.03K | ﹤0.01% | 588 |
|
|
2024
Q1 | $6.5K | Buy |
24
+1
| +4% | +$271 | ﹤0.01% | 574 |
|
|
2023
Q4 | $5.44K | Buy |
23
+8
| +53% | +$1.89K | ﹤0.01% | 592 |
|
|
2023
Q3 | $2.94K | Hold |
15
| – | – | ﹤0.01% | 625 |
|
|
2023
Q2 | $3.15K | Buy |
15
+7
| +88% | +$1.47K | ﹤0.01% | 620 |
|
|
2023
Q1 | $1.62K | Buy |
8
+1
| +14% | +$202 | ﹤0.01% | 653 |
|
|
2022
Q4 | $1.53K | Buy |
7
+1
| +17% | +$218 | ﹤0.01% | 623 |
|
|
2022
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 647 |
|
|
2022
Q2 | $1K | Sell |
6
-5
| -45% | -$833 | ﹤0.01% | 643 |
|
|
2022
Q1 | $3K | Buy |
11
+8
| +267% | +$2.18K | ﹤0.01% | 628 |
|
|
2021
Q4 | $1K | Sell |
3
-4
| -57% | -$1.33K | ﹤0.01% | 673 |
|
|
2021
Q3 | $3K | Buy |
+7
| New | +$3K | ﹤0.01% | 635 |
|
|
2018
Q4 | – | Sell |
-45
| Closed | -$6K | – | 328 |
|
|
2018
Q3 | $6K | Hold |
45
| – | – | ﹤0.01% | 283 |
|
|
2018
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 308 |
|
|
2018
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 305 |
|
|
2017
Q4 | $5K | Buy |
+45
| New | +$5K | ﹤0.01% | 299 |
|